KEFEA aims to boost credibility at European level

Transfers of value made by pharmaceutical companies involving the expenses incurred in relation to healthcare professionals and healthcare organizations are to be made public for the first time by the end of June as part of a European-wide initiative to enforce stricter self-regulation of the industry and boost transparency, the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA).

Details about the initiative were announced at a working breakfast with journalists on “Responsible Transparency – Disclosure Code,” organized by KEFEA.

KEFEA president Kyriakos Mikellis said that, by the end of June, in Cyprus and throughout Europe, European Federation of Pharmaceutical Industries and Associations (EFPIA) member companies will for the first time disclose information regarding, among other, grants to scientific organizations, consultancy fees for speeches, and payment of costs for healthcare professionals to attend medical conferences in Cyprus and abroad. They also include the cost of registration, accommodation and travel to conference venues.